Weijie Liao

Prof. Weijie Liao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
JQJiading Qin
Jiading Qin
LZLing Zhang
Ling Zhang
GZGuangcheng Zhang
Guangcheng Zhang
WLWeijie Liao
Weijie Liao
LYLi Yu
Li Yu
Dietary factors may have a causative influence on acute myeloid leukemia (AML), a hematologic cancer known to be highly fatal. It is still mostly unknown whether causal mechanisms connect dietary exposures to AML, particularly through the gut microbiota and host metabolism. A two‐sample Mendelian randomization (MR) analysis was conducted using genome‐wide association study (GWAS) data to assess the causal effect of 20 routine dietary factors on AML. A two‐step MR framework was employed to assess the mediating roles of gut microbiota and host metabolites. Sensitivity analyses, including inverse variance weighted (IVW), MR‐Egger, and MR‐PRESSO, were performed to ensure the robustness of results. Processed meat consumption was causally associated with an increased risk of AML (IVW OR = 15.111; 95% CI = 1.253–182.262; p = 0.033). The gut microbiota‐associated L‐histidine degradation I pathway was identified as a pro‐carcinogenic mediator, accounting for 19.5% of the effect. Conversely, host metabolites, including circulating glycerol levels and the free cholesterol‐to‐total lipids ratio in very large high‐density lipoprotein (HDL), functioned as protective mediators. No substantial horizontal pleiotropy or heterogeneity was observed, thereby reinforcing the validity of these findings. This research offers a new understanding of the role of processed meat in the development of AML via the microbiota‐metabolite axis and emphasizes possible metabolic compensatory pathways.

20 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TZTian Zhang
Tian Zhang
YDYing Deng
Ying Deng
WWWentao Wang
Wentao Wang
ZZZhe Zhao
Zhe Zhao
YWYiling Wu
Yiling Wu
WLWeijie Liao
Weijie Liao
The prompt diagnosis of pulmonary infections with unknown etiology in patients in severe condition remains a challenge due to the lack of rapid and effective diagnostic methods. While metatranscriptomic sequencing offers a powerful approach, its clinical utility is often limited by issues of timeliness. In this study, we conducted metatranscriptomic sequencing on bronchoalveolar lavage fluid (BALF) collected from critically ill, severely ill, and ICU patients. Based on microbial detection results, patients were classified into four types: negative, bacterial infection, viral infection, and fungal infection. To identify host gene expression signatures associated with infection, we screened characteristic genes from human metatranscriptomic data by comparing 70% of patients with confirmed infections vs. non-infections. Leveraging these characteristic genes, we constructed classification sub-models employing 13 types of machine learning algorithms, and we further integrated these sub-models into stacking-based ensemble models with Lasso regression, resulting in diagnostic models that required only a small set of gene expression inputs. The average performance of five-fold cross-validation demonstrated high diagnostic accuracy: distinguishing infection from non-infection (AUC = 0.984), bacterial infection from non-bacterial infection (AUC = 0.98), and viral infection from non- viral infection (AUC = 0.98). Test cohorts’ results demonstrated the method’s high diagnostic accuracy consistency with metatranscriptomic sequencing in discerning patient infection status (AUC = 0.865) and the type of infection (viral: AUC = 0.934, bacterial: AUC = 0.871). Our study presented a rapid and inexpensive adjunctive diagnostic strategy that achieves diagnostic accuracy comparable to metatranscriptomic sequencing, enabling timely identification of both infection status and type in pulmonary infections.

13 October 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
WLWeijie Liao
Weijie Liao
TZTian Zhang
Tian Zhang
JCJiaxing Cao
Jiaxing Cao
SWSongmao Wang
Songmao Wang
YZYaou Zhang
Yaou Zhang
Despite its critical role in organ protection, angiotensin-converting enzyme 2 (ACE2) is paradoxically downregulated during SARS-CoV-2 infection, contributing to multi-organ dysfunction in COVID-19. The mechanisms driving this loss, particularly those mediated by long non-coding RNAs (lncRNAs), are unknown. Through transcriptomic analysis, we identified that the lncRNA EPB41L4A-AS1 (EAS1) is consistently upregulated upon infection by multiple coronaviruses, including SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E. Mechanistically, SARS-CoV-2 infection activates HIF-1α, which binds to an enhancer element within the EAS1 locus to drive its expression. Subsequently, EAS1 recruits the acetyltransferase GCN5 to catalyze the acetylation of the transcriptional coactivator PGC1β. This modification disrupts the interaction between PGC1β and the transcription factor PPARγ, thereby impairing PPARγ-mediated transactivation of the ACE2 gene and leading to its transcriptional repression. Functionally, we demonstrate that this EAS1-mediated suppression of ACE2 exacerbates cellular apoptosis induced by TNF-α and hypoxia, two key pathological features of severe COVID-19. Our study unveils a novel epigenetic pathway through which SARS-CoV-2 dysregulates ACE2 expression and promotes cellular damage. Given the persistent threat of recurrent coronavirus spillovers, the conserved upregulation of EAS1 across distinct coronavirus genera suggests it may represent a potential therapeutic target for mitigating organ injury in COVID-19. Furthermore, our findings that the EAS1-ACE2 axis mediates apoptosis in response to hypoxia and cytokine signaling warrant future investigation into its role in other pathological contexts beyond viral infection.

10 March 2025 in Genome Instability & Disease
Verified
Journal Article
Closed access
PDF file
HSHaiyu Song
Haiyu Song
RWRuiqi Wang
Ruiqi Wang
WLWeijie Liao
Weijie Liao
LYLi Yu
Li Yu